Showing 1,277 results

Filters Content type: News, Editors' picks, About HIV Topic: New & experimental HIV treatments

News and information about clinical trials and regulatory approval of new medications to treat HIV.

Pharmaceutical industry

Gilead And The Future of HIV Therapy

Editor's pick
The Street
10 April 2012
New & experimental HIV treatments

GSK's new once-daily HIV drug matches Merck rival

Editor's pick
Reuters
2 April 2012
New & experimental HIV treatments

Shionogi-ViiV Healthcare Announces Initial Data from Pivotal Phase III Study

Editor's pick
ViiV Healthcare (press release)
2 April 2012
HIV treatment for children & young people

FDA Approves INTELENCE® (etravirine) Tablets for Treatment-Experienced Pediatric Patients with HIV-1

Editor's pick
Janssen press release
28 March 2012
New & experimental HIV treatments

Avexa closer to EMA approval for ATC

Editor's pick
Australian Life Scientist
23 March 2012
New & experimental HIV treatments

Marijuana and its CD4 Receptors: A New HIV Treatment Strategy?

Editor's pick
AIDSMeds.com
21 March 2012
Cardiovascular disease

CROI 2012 Really Rapid Review, by Dr Paul Sax

Editor's pick
The Body
21 March 2012
New & experimental HIV treatments

Elvitegravir Quad pill matches efavirenz and atazanavir combos

News
13 March 2012
The search for a cure

Zolinza May Help Reduce Latent HIV Reservoirs In People With HIV (CROI 2012)

Editor's pick
The AIDS Beacon
10 March 2012
New & experimental HIV treatments

ViiV Announces Expanded Access to Once-a-Day Integrase Inhibitor ... But Activists Are Concerned About Its Potential Misuse

Editor's pick
The Body
9 March 2012
The search for a cure

Drug brings HIV out of hiding

Editor's pick
Nature
9 March 2012
New & experimental HIV treatments

Novel integrase inhibitor dolutegravir still potent at 96 weeks

News
9 March 2012
TB treatment

High dose of new HIV drug might improve outcomes for HIV/TB co-infected

Editor's pick
Science Speaks
8 March 2012
New & experimental HIV treatments

Tenofovir pro-drug GS-7340 shows good safety and efficacy in short study

News
8 March 2012
New & experimental HIV treatments

Gilead's Quad Single Tablet Regimen For HIV Non-Inferior To Atripla In Study

Editor's pick
NASDAQ
7 March 2012
New & experimental HIV treatments

ViiV's Dolutegravir Continues to Show Well After 96 Weeks, Versus Sustiva, for First-Time Treatment

Editor's pick
AIDSMeds
7 March 2012
Injectable & long-acting PrEP

Once-a-month HIV drug maintains good levels for prevention; few side-effects so far

News
7 March 2012
New & experimental HIV treatments

Early Access Program for Integrase Inhibitor Dolutegravir Launched

Editor's pick
AIDSMeds
5 March 2012
New & experimental HIV treatments

Norwegian HIV vaccine—Very modest results seen in recent clinical trial

Editor's pick
CATIE
22 February 2012
HIV treatment

Model Explains Efficacy of HIV Drugs

Editor's pick
MedPage Today
19 February 2012
The search for an HIV prevention vaccine

Results for viral load on Vacc-4x

Editor's pick
Bionor Pharma
16 February 2012
Clinical trials

HIV Experts Propose New Pathway for Conducting Phase 3 Drug Trials

Editor's pick
Forum for Collaborative HIV Research
7 February 2012
New & experimental HIV treatments

New Gilead GS 7340-Inclusive Fixed-Dose Combo Tablet Trial Announced

Editor's pick
AIDSMeds
30 January 2012
New & experimental HIV treatments

Gilead Initiates Phase 2 Clinical Trial Evaluating GS-7340, A Low-Dose Novel Prodrug of Tenofovir

Editor's pick
Gilead press release
24 January 2012